About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 305964, 8 pages
http://dx.doi.org/10.1155/2012/305964
Research Article

Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia

1Department of Biomedicine, University Women's Hospital, 4031 Basel, Switzerland
2Biozentrum, University of Basel, 4056 Basel, Switzerland
3Laboratory for Prenatal Medicine, Department of Biomedicine, University Women's Hospital, Hebelstrasse 20, CH 4031 Basel, Switzerland

Received 31 May 2011; Revised 26 December 2011; Accepted 28 December 2011

Academic Editor: Saulius Butenas

Copyright © 2012 Varaprasad Kolla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Hogan, K. J. Foreman, M. Naghavi et al., “Maternal mortality for 181 countries, 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5,” The Lancet, vol. 375, no. 9726, pp. 1609–1623, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Jim, S. Sharma, T. Kebede, and A. Acharya, “Hypertension in pregnancy: a comprehensive update,” Cardiology in Review, vol. 18, no. 4, pp. 178–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. A. Steegers, “Pre-eclampsia,” The Lancet, vol. 376, no. 9741, pp. 631–644, 2010.
  4. M. Silasi, B. Cohen, S. A. Karumanchi, and S. Rana, “Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia,” Obstetrics and Gynecology Clinics of North America, vol. 37, no. 2, pp. 239–253, 2010. View at Publisher · View at Google Scholar
  5. S. Y. Kim, H. M. Ryu, J. H. Yang et al., “Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia,” Journal of Korean Medical Science, vol. 21, no. 3, pp. 452–456, 2006. View at Scopus
  6. S. Y. Kim, H. M. Ryu, J. H. Yang et al., “Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia,” Journal of Korean Medical Science, vol. 22, no. 5, pp. 873–877, 2007. View at Scopus
  7. K. Spencer, N. J. Cowans, and A. Stamatopoulou, “ADAM12s in maternal serum as a potential marker of pre-eclampsia,” Prenatal Diagnosis, vol. 28, no. 3, pp. 212–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Akolekar, A. Syngelaki, J. Beta, R. Kocylowski, and K. H. Nicolaides, “Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia,” Prenatal Diagnosis, vol. 29, no. 12, pp. 1103–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Khalil, N. J. Cowans, K. Spencer, S. Goichman, H. Meiri, and K. Harrington, “First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk,” Prenatal Diagnosis, vol. 29, no. 8, pp. 781–789, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Spencer, N. J. Cowans, and K. H. Nicolaides, “Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia,” Prenatal Diagnosis, vol. 28, no. 1, pp. 7–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. E. R. Norwitz, “Defective implantation and placentation: laying the blueprint for pregnancy complications,” Reproductive BioMedicine Online, vol. 13, no. 4, pp. 591–599, 2006. View at Scopus
  12. M. Blumenstein, M. T. McMaster, M. A. Black et al., “A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease,” Proteomics, vol. 9, no. 11, pp. 2929–2945, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. L. Ross, Y. N. Huang, J. N. Marchese et al., “Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents,” Molecular and Cellular Proteomics, vol. 3, no. 12, pp. 1154–1169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. K. Chong, C. S. Gan, T. K. Pham, and P. C. Wright, “Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: implication of multiple injections,” Journal of Proteome Research, vol. 5, no. 5, pp. 1232–1240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Song, J. Bandow, J. Sherman et al., “iTRAQ experimental design for plasma biomarker discovery,” Journal of Proteome Research, vol. 7, no. 7, pp. 2952–2958, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Kolla, P. Jenö, S. Moes et al., “Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ),” Journal of Biomedicine & Biotechnology, vol. 2010, Article ID 952047, 10 pages, 2010. View at Scopus
  17. R. D. Unwin, A. Pierce, R. B. Watson, D. W. Sternberg, and A. D. Whetton, “Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells,” Molecular and Cellular Proteomics, vol. 4, no. 7, pp. 924–935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. E. Elias and S. P. Gygi, “Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry,” Nature Methods, vol. 4, no. 3, pp. 207–214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. I. V. Shilov, S. L. Seymourt, A. A. Patel et al., “The paragon algorithm, a next generation search engine that uses sequence temperature values sequence temperature values and feature probabilities to identify peptides from tandem mass spectra,” Molecular and Cellular Proteomics, vol. 6, no. 9, pp. 1638–1655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Mi, N. Guo, A. Kejariwal, and P. D. Thomas, “PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways,” Nucleic Acids Research, vol. 35, no. 1, pp. D247–D252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Glen, C. S. Gan, F. C. Hamdy et al., “ITRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression,” Journal of Proteome Research, vol. 7, no. 3, pp. 897–907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. S. Gan, K. C. Poh, K. P. Trong, and P. C. Wright, “Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ),” Journal of Proteome Research, vol. 6, no. 2, pp. 821–827, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. W. Mosesson, “Fibrinogen and fibrin structure and functions,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1894–1904, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. N. E. Kirschbaum, M. W. Mosesson, and D. L. Amrani, “Characterization of the γ chain platelet binding site on fibrinogen fragment D,” Blood, vol. 79, no. 10, pp. 2643–2648, 1992. View at Scopus
  25. C. Benoit, J. Zavecz, and Y. Wang, “Vasoreactivity of Chorionic Plate Arteries in Response to Vasoconstrictors Produced by Preeclamptic Placentas,” Placenta, vol. 28, no. 5-6, pp. 498–504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. G. Leeflang, J. S. Cnossen, J. A. M. van der Post, B. W. J. Mol, K. S. Khan, and G. ter Riet, “Accuracy of fibronectin tests for the prediction of pre-eclampsia: a systematic review,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 133, no. 1, pp. 12–19, 2007. View at Publisher · View at Google Scholar
  27. L. Anton, D. C. Merrill, L. A. A. Neves et al., “Activation of local chorionic villi angiotensin II levels but not angiotensin (1–7) in preeclampsia,” Hypertension, vol. 51, no. 4, pp. 1066–1072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. E. L. Skornicka, N. Kiyatkina, M. C. Weber, M. L. Tykocinski, and P. H. Koo, “Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production,” Cellular Immunology, vol. 232, no. 1-2, pp. 144–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. K. R. Atkinson, M. Blumenstein, M. A. Black et al., “An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia,” Journal of Lipid Research, vol. 50, no. 1, pp. 71–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Lange, P. Picotti, B. Domon, and R. Aebersold, “Selected reaction monitoring for quantitative proteomics: a tutorial,” Molecular Systems Biology, vol. 4, article no. 222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Picotti, B. Bodenmiller, L. N. Mueller, B. Domon, and R. Aebersold, “Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics,” Cell, vol. 138, no. 4, pp. 795–806, 2009. View at Publisher · View at Google Scholar · View at Scopus